Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut
#ObesityMedicine #Medicare #GLP1 #PatientAccess #PriorAuthorization FAQ Continued: 16
As outlined in , the medication isnt FDA-approved in 2026, which means theres no standard pharmacy priceonly a wide range based on access pathways, dosing, and level of medical oversight
Biol Psychiatry 79:489498 Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A (2022) The role of glucagon-like peptide 1 (GLP-1) in addictive disorders
Even in India, early access to innovator brands like Novo Nordisk Ozempic and Wegovy (both semaglutide), plus Rybelsus, Victoza, and Trulicity, meant bills of 10,00020,000 per month for many patients, putting these drugs out of reach for the average middle-class household
The questions we can't yet answer matter enormously: Does it resolve or persist long-term